secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0000950170-22-011171
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dyne Therapeutics shareholders elect Hurwitz and Kersten to board, ratify auditor
--------------------------------------------------------------------------------

- Edward Hurwitz elected as Class II director: 20,392,039 for, 7,406,127 withheld, 3,170,612 broker non-votes.
- Dirk Kersten elected as Class II director: 20,066,236 for, 7,731,930 withheld, 3,170,612 broker non-votes.
- Ratified Deloitte & Touche as auditor for FY2022: 30,967,416 for, 362 against, 1,000 abstain.
- Annual meeting held June 3, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/0000950170-22-011171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/dyn-20220603.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer